Clinical Trial Update: Study to Evaluate the Safety and Efficacy of CAT-354 [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of CAT-354 in asthma has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• CAT-354

Snippet

Sponsor: MedImmune LLC | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2017-02-23